心血管超音波心动图市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按类型、技术、最终用户和地理位置

心血管超音波心臟检查市场规模预计将从2022年的1,437.2亿美元成长到2030年的2,000亿美元；预计 2022 年至 2030 年复合年增长率为 4.2%。

心血管超音波心动图是一种使用声波创建心臟影像的测试。此测试程序通常针对疑似或已知患有心臟病的患者进行。此测试无痛，可揭示心臟状况；此影像显示了心臟的大小、形状、心室和瓣膜及其功能。心血管超音波心动图还可以辨识心臟收缩不正常的部分。使用超音波心动图可以清楚地看到早期心臟病发作造成的损伤。用于检测心臟疾病的常用诊断测试是经胸心臟超音波检查，因为它是非侵入性的。心血管超音波心动图市场的成长归因于心血管疾病负担的增加以及超音波心动图设备相对于其他心臟诊断程序的优势。然而，与超音波心动图设备的使用相关的挑战阻碍了心血管超音波心动图市场的成长。

基于类型的见解

根据技术，心血管超音波心臟检查市场分为2D超音波心臟检查、3D超音波心动图和多普勒。到 2022 年，3D 超音波心动图细分市场将占据重要的心血管超音波心动图市场份额。 3D 超音波心动图捕捉心臟结构的三维影像，用于提高影像品质和读者信心并评估结构和功能。透过在心臟跳动时进行测量，即时影像可以更准确地评估心臟功能。心臟病患者的最佳治疗方案可以透过 3D 回波来决定，它提供了心臟解剖结构的改进影像。在过去的二十年中，电脑和换能器技术的进步促进了 3D 超音波心动图的发展，它为传统 2D 超音波心动图提供了重要的附加临床资讯。与 2D 超音波心动图相比，3D 超音波心动图具有许多优点，例如更好地定量心臟体积、质量和功能，更好地显示和评估瓣膜功能障碍；和更短的影像撷取时间。它还可以改善心臟结构之间复杂形状和空间关係的可视化，这对心血管超音波心动图市场的成长有正面影响。

基于指示的见解

根据最终用户，心血管超音波心臟检查市场分为医院、门诊手术中心和诊断实验室。医院细分市场在 2022 年占据重要市场份额，预计 2022 年至 2030 年复合年增长率最高。

美国食品药物管理局、世界卫生组织和疾病管制与预防中心是准备心血管超音波心动图市场报告时参考的主要和次要来源之一。

目录

第 1 章：简介

第 2 章：执行摘要

• 重要见解
• 市场吸引力分析

第 3 章：研究方法

第 4 章：心血管超音波心臟检查市场格局

• 概述
• PEST分析
• 生态系分析
  • 价值链供应商名单

第 5 章：心血管超音波心臟检查市场 - 主要市场动态

• 主要市场驱动因素
• 主要市场限制
• 主要市场机会
• 未来的趋势
• 驱动因素和限制因素的影响分析

第 6 章：心血管超音波心臟检查市场 - 全球市场分析

• 心血管超音波心臟检查 - 全球市场概览
• 心血管超音波心臟检查 - 全球市场和 2031 年预测

第 7 章：心血管超音波心动图市场 - 收入分析 - 按类型，2021-2031

• 概述
• 经胸超音波心臟检查
• 经食道心臟超音波
• 负荷超音波心臟检查
• 胎儿超音波心臟检查

第 8 章：心血管超音波心动图市场 - 收入分析 - 按技术划分，2021-2031 年

• 概述
• 二维超音波心动图
• 3D超音波心臟检查
• 多普勒

第 9 章：心血管超音波心动图市场 - 收入分析 - 按最终用户，2021-2031 年

• 概述
• 医院
• 门诊手术中心
• 诊断实验室

第 10 章：心血管超音波心动图市场 - 收入分析，2021-2031 - 地理分析

• 北美洲
  • 美国
  • 加拿大
  • 墨西哥

註 - 将为以下提到的地区/国家提供类似的分析

• 欧洲
  • 德国
  • 法国
  • 义大利
  • 西班牙
  • 英国
  • 欧洲其他地区
• 亚太
  • 澳洲
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
• 南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区

第 11 章：产业格局

• 併购
• 协议、合作、合资企业
• 新产品发布
• 扩张和其他策略发展

第 12 章：竞争格局

• 关键参与者的热图分析
• 公司定位与专注

第 13 章：心血管超音波心动图市场 - 主要公司概况

• Apex Heart and Vascular
• Ultra-X Imaging
• Metropolitan Heart Vascular Institute
• Ultromics Limited
• Corewell Health
• Centinela Hospital Medical Center
• Schoolcraft Memorial Hospital
• University of Utah Health
• Goshen Heart and Vascular Center
• Harefield Hospital

第 14 章：附录

The cardiovascular echocardiography market size is expected to grow from US$ 143.72 billion in 2022 to US$ 200.00 billion by 2030; it is projected to register a CAGR of 4.2% during 2022-2030.

Cardiovascular echocardiography is a test that uses sound waves to create images of the heart. This testing procedure is usually performed on patients with suspected or known heart diseases. The test is painless and reveals the condition of the heart; the image shows the size, shape, chambers, and valves of the heart and their functioning. The cardiovascular echocardiogram can also identify parts of the heart that are not contracting properly. The injuries from the earlier heart attack can be clearly visualized using echocardiographs. The commonly used diagnostic test for detecting cardiac disorders is transthoracic cardiac ultrasound owing to its non-invasive nature. The cardiovascular echocardiography market growth is attributed to the rising burden of cardiovascular diseases and the advantages of echocardiographic devices over other cardiac diagnostic procedures. However, challenges associated with the use of echocardiography devices hinder the growth of the cardiovascular echocardiography market.

Type-Based Insights

Based on technology, the cardiovascular echocardiography market is categorized into 2D echocardiogram, 3D echocardiogram, and Doppler. The 3D echocardiogram segment held a significant cardiovascular echocardiography market share in 2022. The segment is estimated to register the highest CAGR during the forecast period. The 3D echocardiogram captures three-dimensional images of the heart structures and is used to improve image quality and reader confidence and assess structure and functionality. With measurements made while the heart is beating, the real-time images offer a more accurate evaluation of cardiac function. The best course of treatment for a patient with heart disease can be decided with the 3-D echo, which provides improved images of the heart's anatomy. Over the past two decades, advancements in computer and transducer technologies have allowed the development of 3D echocardiography, which provides significant additional clinical information to traditional 2D echocardiography. Compared to 2D echocardiography, 3D echocardiography offers numerous benefits, such as better quantitation of cardiac volumes, mass, and function, better display and assessment of valve dysfunction; and shorter image acquisition times. It also allows for improved visualization of complex shapes and spatial relations between cardiac structures, which positively influences the growth of the cardiovascular echocardiography market.

Indication-Based Insights

Based on end user, the cardiovascular echocardiography market is segmented into hospitals, ambulatory surgery centers, and diagnostic labs. The hospitals segment held a significant market share in 2022 and is expected to register the highest CAGR during 2022-2030.

The US Food and Drug Administration, the World Health Organization, and the Centers for Disease Control and Prevention are among the primary and secondary sources referred to while preparing the cardiovascular echocardiography market report.

Table Of Contents

1. Introduction

• 1.1 Scope of the Study
• 1.2 Market Definition, Assumptions and Limitations
• 1.3 Market Segmentation

2. Executive Summary

• 2.1 Key Insights
• 2.2 Market Attractiveness Analysis

3. Research Methodology

4. Cardiovascular Echocardiography Market Landscape

• 4.1 Overview
• 4.2 PEST Analysis
• 4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Cardiovascular Echocardiography Market - Key Market Dynamics

• 5.1 Key Market Drivers
• 5.2 Key Market Restraints
• 5.3 Key Market Opportunities
• 5.4 Future Trends
• 5.5 Impact Analysis of Drivers and Restraints

6. Cardiovascular Echocardiography Market - Global Market Analysis

• 6.1 Cardiovascular Echocardiography - Global Market Overview
• 6.2 Cardiovascular Echocardiography - Global Market and Forecast to 2031

7. Cardiovascular Echocardiography Market - Revenue Analysis (USD Million) - By Type, 2021-2031

• 7.1 Overview
• 7.2 Transthoracic Echocardiography
• 7.3 Transesophageal Echocardiography
• 7.4 Stress Echocardiography
• 7.5 Fetal Echocardiography

8. Cardiovascular Echocardiography Market - Revenue Analysis (USD Million) - By Technology, 2021-2031

• 8.1 Overview
• 8.2 2D echocardiogram
• 8.3 3D echocardiogram
• 8.4 Doppler

9. Cardiovascular Echocardiography Market - Revenue Analysis (USD Million) - By End User, 2021-2031

• 9.1 Overview
• 9.2 Hospitals
• 9.3 Ambulatory Surgery Centers
• 9.4 Diagnostic Labs

10. Cardiovascular Echocardiography Market - Revenue Analysis (USD Million), 2021-2031 - Geographical Analysis

• 10.1 North America
  • 10.1.1 North America Cardiovascular Echocardiography Market Overview
  • 10.1.2 North America Cardiovascular Echocardiography Market Revenue and Forecasts to 2031
  • 10.1.3 North America Cardiovascular Echocardiography Market Revenue and Forecasts and Analysis - By Type
  • 10.1.4 North America Cardiovascular Echocardiography Market Revenue and Forecasts and Analysis - By Technology
  • 10.1.5 North America Cardiovascular Echocardiography Market Revenue and Forecasts and Analysis - By End User
  • 10.1.6 North America Cardiovascular Echocardiography Market Revenue and Forecasts and Analysis - By Countries
    • 10.1.6.1 United States Cardiovascular Echocardiography Market
      • 10.1.6.1.1 United States Cardiovascular Echocardiography Market, by Type
      • 10.1.6.1.2 United States Cardiovascular Echocardiography Market, by Technology
      • 10.1.6.1.3 United States Cardiovascular Echocardiography Market, by End User
    • 10.1.6.2 Canada Cardiovascular Echocardiography Market
      • 10.1.6.2.1 Canada Cardiovascular Echocardiography Market, by Type
      • 10.1.6.2.2 Canada Cardiovascular Echocardiography Market, by Technology
      • 10.1.6.2.3 Canada Cardiovascular Echocardiography Market, by End User
    • 10.1.6.3 Mexico Cardiovascular Echocardiography Market
      • 10.1.6.3.1 Mexico Cardiovascular Echocardiography Market, by Type
      • 10.1.6.3.2 Mexico Cardiovascular Echocardiography Market, by Technology
      • 10.1.6.3.3 Mexico Cardiovascular Echocardiography Market, by End User

Note - Similar analysis would be provided for below mentioned regions/countries

• 10.2 Europe
  • 10.2.1 Germany
  • 10.2.2 France
  • 10.2.3 Italy
  • 10.2.4 Spain
  • 10.2.5 United Kingdom
  • 10.2.6 Rest of Europe
• 10.3 Asia-Pacific
  • 10.3.1 Australia
  • 10.3.2 China
  • 10.3.3 India
  • 10.3.4 Japan
  • 10.3.5 South Korea
  • 10.3.6 Rest of Asia-Pacific
• 10.4 Middle East and Africa
  • 10.4.1 South Africa
  • 10.4.2 Saudi Arabia
  • 10.4.3 U.A.E
  • 10.4.4 Rest of Middle East and Africa
• 10.5 South and Central America
  • 10.5.1 Brazil
  • 10.5.2 Argentina
  • 10.5.3 Rest of South and Central America

11. Industry Landscape

• 11.1 Mergers and Acquisitions
• 11.2 Agreements, Collaborations, Joint Ventures
• 11.3 New Product Launches
• 11.4 Expansions and Other Strategic Developments

12. Competitive Landscape

• 12.1 Heat Map Analysis by Key Players
• 12.2 Company Positioning and Concentration

13. Cardiovascular Echocardiography Market - Key Company Profiles

• 13.1 Apex Heart and Vascular
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments

Note - Similar information would be provided for below list of companies

• 13.2 Ultra-X Imaging
• 13.3 Metropolitan Heart Vascular Institute
• 13.4 Ultromics Limited
• 13.5 Corewell Health
• 13.6 Centinela Hospital Medical Center
• 13.7 Schoolcraft Memorial Hospital
• 13.8 University of Utah Health
• 13.9 Goshen Heart and Vascular Center
• 13.10 Harefield Hospital

14. Appendix

• 14.1 Glossary
• 14.2 About The Insight Partners
• 14.3 Market Intelligence Cloud